Guidance

Hib/MenC: patient group direction (PGD) template

PGD template to support the national Haemophilus influenzae type b and meningococcal C conjugate vaccination programme.

Documents

Hib/MenC: patient group direction (PGD) template

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This patient group direction (PGD) template supports the administration of Haemophilus influenzae type b (Hib) and meningococcal C conjugate vaccine to individuals from their first birthday to under 10 years of age in accordance with the national immunisation programme; and to individuals of any age for the prevention of secondary cases of meningococcal group C (MenC) disease in accordance with the Guidance for the public health management of meningococcal disease in the UK.

It is valid from 1 August 2018 to 31 July 2020.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy/procedures to access authorised PGD documents.

This PGD template should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.

Published 4 February 2016
Last updated 3 July 2018 + show all updates
  1. Updated template to align with new guidance for the public health management of Meningococcal disease in the UK.
  2. Updated to reflect removal of monovalent MenC from routine programme.
  3. First published.